Information for "Immunogenomics involving intestines adenocarcinoma Success variations manifested by immune receptor CDR3 compound capabilities as well as expression involving BTN gene members of the family"
From EECH Central
Basic information
| Display title | Immunogenomics involving intestines adenocarcinoma Success variations manifested by immune receptor CDR3 compound capabilities as well as expression involving BTN gene members of the family |
| Default sort key | Immunogenomics involving intestines adenocarcinoma Success variations manifested by immune receptor CDR3 compound capabilities as well as expression involving BTN gene members of the family |
| Page length (in bytes) | 3,413 |
| Page ID | 1402977 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Houseatm2 (Talk | contribs) |
| Date of page creation | 07:41, 25 April 2024 |
| Latest editor | Houseatm2 (Talk | contribs) |
| Date of latest edit | 07:41, 25 April 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
